{
  "file_id": "981243fa95401e7d3df08cc66072a86cd4ba0ecd07f5c7cdc13e5c17d61bf2ef",
  "page_url": "https://journals.lww.com/hep/fulltext/2022/09000/aasld_practice_guidance__palliative_care_and.28.aspx",
  "page_title": "Hepatology",
  "content_type": "html",
  "crawled_at": "2025-11-11T20:25:55.371840+00:00",
  "accessible": true,
  "content": {
    "full_text": "AASLD Publications Liver Transplantation Hepatology Communications Clinical Liver Disease AASLD Publications Liver Transplantation Hepatology Communications Clinical Liver Disease AASLD Publications Liver Transplantation Hepatology Communications Clinical Liver Disease Subscribe Get alerts Secondary Logo Subscribe Register Login Home Browse Articles in Press Current Issue All Issues Collections Video Gallery Review Articles Graphical Abstracts Top Cited Articles Top Altmetric Articles Multi-journal Article Collections The Future of Hepatology2024 Impact Factor: Top Cited Articles About About the Journal About AASLDEditorial Board Instructions for Authors Advertising Permissions Open Access Reprints For Authors Instructions for Authors Submit an Article Language Editing Services Graphical Abstract Guidelines Author Promotion Toolkit Resources Publish with Us AASLD Career Center Joint GI Society Statement on Racism What is Hepatology looking for 2.0? COVID-19 Resources Liver Learning Liver Connect Forums Become a Member AASLD Guidelines Submit an Article September 2022 - Volume 76 - Issue 3Previous Article Next Article for this Video.. Hepatic ischemia reperfusion injury: Underlying mechanisms and concepts in liver surgery and liver transplantation Semaglutide therapy for metabolic dysfunction-associated steatohepatitis: November 2025 updates to AASLD Practice Guidance Introducing Saul J. Karpen, MD, Ph D, the 77th President of AASLDEpigenetic repression of hepatocyte Fox O1 disrupts local immune homeostasis and promotes liver inflammation Reply: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment Letter to the Editor: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment AASLD Practice Guidance on risk stratification and management of portal... Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial... AASLD Practice Guidance on the clinical assessment and management of... Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in... AASLD Practice Guidance on prevention, diagnosis, and treatment of... Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma AASLD guidelines for treatment of chronic hepatitis B sent right to your email inbox Browse Journal Content Register on the website Subscribe Get e TOC Alerts Support:Legal Disclaimer Terms of Use Open Access Policy Your California Privacy Choices -Wolters Kluwer Health, Inc. All rights reserved. | . Subscribe Get alerts Secondary Logo Subscribe Register Login Home Browse Articles in Press Current Issue All Issues Collections Video Gallery Review Articles Graphical Abstracts Top Cited Articles Top Altmetric Articles Multi-journal Article Collections The Future of Hepatology2024 Impact Factor: Top Cited Articles About About the Journal About AASLDEditorial Board Instructions for Authors Advertising Permissions Open Access Reprints For Authors Instructions for Authors Submit an Article Language Editing Services Graphical Abstract Guidelines Author Promotion Toolkit Resources Publish with Us AASLD Career Center Joint GI Society Statement on Racism What is Hepatology looking for 2.0? COVID-19 Resources Liver Learning Liver Connect Forums Become a Member AASLD Guidelines Submit an Article September 2022 - Volume 76 - Issue 3Previous Article Next Article for this Video.. Hepatic ischemia reperfusion injury: Underlying mechanisms and concepts in liver surgery and liver transplantation Semaglutide therapy for metabolic dysfunction-associated steatohepatitis: November 2025 updates to AASLD Practice Guidance Introducing Saul J. Karpen, MD, Ph D, the 77th President of AASLDEpigenetic repression of hepatocyte Fox O1 disrupts local immune homeostasis and promotes liver inflammation Reply: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment Letter to the Editor: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment AASLD Practice Guidance on risk stratification and management of portal... Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial... AASLD Practice Guidance on the clinical assessment and management of... Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in... AASLD Practice Guidance on prevention, diagnosis, and treatment of... Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma AASLD guidelines for treatment of chronic hepatitis B sent right to your email inbox Browse Journal Content Register on the website Subscribe Get e TOC Alerts Support:Legal Disclaimer Terms of Use Open Access Policy Your California Privacy Choices -Wolters Kluwer Health, Inc. All rights reserved. | . Subscribe Get alerts Secondary Logo Subscribe Register Login Home Browse Articles in Press Current Issue All Issues Collections Video Gallery Review Articles Graphical Abstracts Top Cited Articles Top Altmetric Articles Multi-journal Article Collections The Future of Hepatology2024 Impact Factor: Top Cited Articles About About the Journal About AASLDEditorial Board Instructions for Authors Advertising Permissions Open Access Reprints For Authors Instructions for Authors Submit an Article Language Editing Services Graphical Abstract Guidelines Author Promotion Toolkit Resources Publish with Us AASLD Career Center Joint GI Society Statement on Racism What is Hepatology looking for 2.0? COVID-19 Resources Liver Learning Liver Connect Forums Become a Member AASLD Guidelines Submit an Article Subscribe Get alerts Secondary Logo Subscribe Get alerts Articles Articles Advanced Search Subscribe Register Login Home Browse Articles in Press Current Issue All Issues Collections Video Gallery Review Articles Graphical Abstracts Top Cited Articles Top Altmetric Articles Multi-journal Article Collections The Future of Hepatology2024 Impact Factor: Top Cited Articles About About the Journal About AASLDEditorial Board Instructions for Authors Advertising Permissions Open Access Reprints For Authors Instructions for Authors Submit an Article Language Editing Services Graphical Abstract Guidelines Author Promotion Toolkit Resources Publish with Us AASLD Career Center Joint GI Society Statement on Racism What is Hepatology looking for 2.0? COVID-19 Resources Liver Learning Liver Connect Forums Become a Member AASLD Guidelines Submit an Article Subscribe Register Login Home Browse Articles in Press Current Issue All Issues Collections Video Gallery Review Articles Graphical Abstracts Top Cited Articles Top Altmetric Articles Multi-journal Article Collections The Future of Hepatology2024 Impact Factor: Top Cited Articles About About the Journal About AASLDEditorial Board Instructions for Authors Advertising Permissions Open Access Reprints For Authors Instructions for Authors Submit an Article Language Editing Services Graphical Abstract Guidelines Author Promotion Toolkit Resources Publish with Us AASLD Career Center Joint GI Society Statement on Racism What is Hepatology looking for 2.0? COVID-19 Resources Liver Learning Liver Connect Forums Become a Member AASLD Guidelines Submit an Article Browse Articles in Press Current Issue All Issues Articles in Press Current Issue Collections Video Gallery Review Articles Graphical Abstracts Top Cited Articles Top Altmetric Articles Multi-journal Article Collections The Future of Hepatology2024 Impact Factor: Top Cited Articles Video Gallery Review Articles Graphical Abstracts Top Cited Articles Top Altmetric Articles Multi-journal Article Collections The Future of Hepatology 2024 Impact Factor: Top Cited Articles About About the Journal About AASLDEditorial Board Instructions for Authors Advertising Permissions Open Access Reprints About the Journal About AASLD Editorial Board Instructions for Authors Advertising Permissions Open Access For Authors Instructions for Authors Submit an Article Language Editing Services Graphical Abstract Guidelines Author Promotion Toolkit Instructions for Authors Submit an Article Language Editing Services Graphical Abstract Guidelines Author Promotion Toolkit Resources Publish with Us AASLD Career Center Joint GI Society Statement on Racism What is Hepatology looking for 2.0? COVID-19 Resources Liver Learning Liver Connect Forums Become a Member Publish with Us AASLD Career Center Joint GI Society Statement on Racism What is Hepatology looking for 2.0? COVID-19 Resources Liver Learning Liver Connect Forums Become a Member AASLD Guidelines Submit an Article Articles Articles Advanced Search September 2022 - Volume 76 - Issue 3Previous Article Next Article for this Video.. Hepatic ischemia reperfusion injury: Underlying mechanisms and concepts in liver surgery and liver transplantation Semaglutide therapy for metabolic dysfunction-associated steatohepatitis: November 2025 updates to AASLD Practice Guidance Introducing Saul J. Karpen, MD, Ph D, the 77th President of AASLDEpigenetic repression of hepatocyte Fox O1 disrupts local immune homeostasis and promotes liver inflammation Reply: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment Letter to the Editor: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment AASLD Practice Guidance on risk stratification and management of portal... Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial... AASLD Practice Guidance on the clinical assessment and management of... Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in... AASLD Practice Guidance on prevention, diagnosis, and treatment of... Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma AASLD guidelines for treatment of chronic hepatitis B September 2022 - Volume 76 - Issue 3Previous Article Next Article for this Video.. Hepatic ischemia reperfusion injury: Underlying mechanisms and concepts in liver surgery and liver transplantation Semaglutide therapy for metabolic dysfunction-associated steatohepatitis: November 2025 updates to AASLD Practice Guidance Introducing Saul J. Karpen, MD, Ph D, the 77th President of AASLDEpigenetic repression of hepatocyte Fox O1 disrupts local immune homeostasis and promotes liver inflammation Reply: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment Letter to the Editor: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment AASLD Practice Guidance on risk stratification and management of portal... Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial... AASLD Practice Guidance on the clinical assessment and management of... Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in... AASLD Practice Guidance on prevention, diagnosis, and treatment of... Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma AASLD guidelines for treatment of chronic hepatitis B September 2022 - Volume 76 - Issue 3Previous Article Next Article for this Video.. Hepatic ischemia reperfusion injury: Underlying mechanisms and concepts in liver surgery and liver transplantation Semaglutide therapy for metabolic dysfunction-associated steatohepatitis: November 2025 updates to AASLD Practice Guidance Introducing Saul J. Karpen, MD, Ph D, the 77th President of AASLDEpigenetic repression of hepatocyte Fox O1 disrupts local immune homeostasis and promotes liver inflammation Reply: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment Letter to the Editor: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment AASLD Practice Guidance on risk stratification and management of portal... Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial... AASLD Practice Guidance on the clinical assessment and management of... Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in... AASLD Practice Guidance on prevention, diagnosis, and treatment of... Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma AASLD guidelines for treatment of chronic hepatitis B September 2022 - Volume 76 - Issue 3Previous Article Next Article September 2022 - Volume 76 - Issue 3Previous Article Next Article September 2022 - Volume 76 - Issue 3Previous Article Next Article September 2022 - Volume 76 - Issue 3Previous Article Next Article September 2022 - Volume 76 - Issue 3Previous Article Next Article September 2022 - Volume 76 - Issue 3Previous Article Next Article September 2022 - Volume 76 - Issue 3Previous Article Next Article September 2022 - Volume 76 - Issue 3Previous Article Next Article September 2022 - Volume 76 - Issue 3Previous Article Next Article September 2022 - Volume 76 - Issue 3 Previous Article Next Article Previous Article Next Article for this Video.. Hepatic ischemia reperfusion injury: Underlying mechanisms and concepts in liver surgery and liver transplantation Semaglutide therapy for metabolic dysfunction-associated steatohepatitis: November 2025 updates to AASLD Practice Guidance Introducing Saul J. Karpen, MD, Ph D, the 77th President of AASLDEpigenetic repression of hepatocyte Fox O1 disrupts local immune homeostasis and promotes liver inflammation Reply: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment Letter to the Editor: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment AASLD Practice Guidance on risk stratification and management of portal... Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial... AASLD Practice Guidance on the clinical assessment and management of... Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in... AASLD Practice Guidance on prevention, diagnosis, and treatment of... Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma AASLD guidelines for treatment of chronic hepatitis B for this Video.. Hepatic ischemia reperfusion injury: Underlying mechanisms and concepts in liver surgery and liver transplantation Semaglutide therapy for metabolic dysfunction-associated steatohepatitis: November 2025 updates to AASLD Practice Guidance Introducing Saul J. Karpen, MD, Ph D, the 77th President of AASLDEpigenetic repression of hepatocyte Fox O1 disrupts local immune homeostasis and promotes liver inflammation Reply: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment Letter to the Editor: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment AASLD Practice Guidance on risk stratification and management of portal... Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial... AASLD Practice Guidance on the clinical assessment and management of... Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in... AASLD Practice Guidance on prevention, diagnosis, and treatment of... Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma AASLD guidelines for treatment of chronic hepatitis B for this Video.. Hepatic ischemia reperfusion injury: Underlying mechanisms and concepts in liver surgery and liver transplantation Semaglutide therapy for metabolic dysfunction-associated steatohepatitis: November 2025 updates to AASLD Practice Guidance Introducing Saul J. Karpen, MD, Ph D, the 77th President of AASLDEpigenetic repression of hepatocyte Fox O1 disrupts local immune homeostasis and promotes liver inflammation Reply: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment Letter to the Editor: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment AASLD Practice Guidance on risk stratification and management of portal... Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial... AASLD Practice Guidance on the clinical assessment and management of... Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in... AASLD Practice Guidance on prevention, diagnosis, and treatment of... Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma AASLD guidelines for treatment of chronic hepatitis B for this Video.. Hepatic ischemia reperfusion injury: Underlying mechanisms and concepts in liver surgery and liver transplantation Semaglutide therapy for metabolic dysfunction-associated steatohepatitis: November 2025 updates to AASLD Practice Guidance Introducing Saul J. Karpen, MD, Ph D, the 77th President of AASLDEpigenetic repression of hepatocyte Fox O1 disrupts local immune homeostasis and promotes liver inflammation Reply: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment Letter to the Editor: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment AASLD Practice Guidance on risk stratification and management of portal... Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial... AASLD Practice Guidance on the clinical assessment and management of... Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in... AASLD Practice Guidance on prevention, diagnosis, and treatment of... Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma AASLD guidelines for treatment of chronic hepatitis B for this Video.. for this Video.. for this Video.. for this Video.. for this Video.. for this Video.. for this Video.. Hepatic ischemia reperfusion injury: Underlying mechanisms and concepts in liver surgery and liver transplantation Semaglutide therapy for metabolic dysfunction-associated steatohepatitis: November 2025 updates to AASLD Practice Guidance Introducing Saul J. Karpen, MD, Ph D, the 77th President of AASLDEpigenetic repression of hepatocyte Fox O1 disrupts local immune homeostasis and promotes liver inflammation Reply: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment Letter to the Editor: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment Hepatic ischemia reperfusion injury: Underlying mechanisms and concepts in liver surgery and liver transplantation Semaglutide therapy for metabolic dysfunction-associated steatohepatitis: November 2025 updates to AASLD Practice Guidance Introducing Saul J. Karpen, MD, Ph D, the 77th President of AASLDEpigenetic repression of hepatocyte Fox O1 disrupts local immune homeostasis and promotes liver inflammation Reply: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment Letter to the Editor: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment Hepatic ischemia reperfusion injury: Underlying mechanisms and concepts in liver surgery and liver transplantation Semaglutide therapy for metabolic dysfunction-associated steatohepatitis: November 2025 updates to AASLD Practice Guidance Introducing Saul J. Karpen, MD, Ph D, the 77th President of AASLDEpigenetic repression of hepatocyte Fox O1 disrupts local immune homeostasis and promotes liver inflammation Reply: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment Letter to the Editor: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment Hepatic ischemia reperfusion injury: Underlying mechanisms and concepts in liver surgery and liver transplantation Semaglutide therapy for metabolic dysfunction-associated steatohepatitis: November 2025 updates to AASLD Practice Guidance Introducing Saul J. Karpen, MD, Ph D, the 77th President of AASLDEpigenetic repression of hepatocyte Fox O1 disrupts local immune homeostasis and promotes liver inflammation Reply: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment Letter to the Editor: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment Hepatic ischemia reperfusion injury: Underlying mechanisms and concepts in liver surgery and liver transplantation Semaglutide therapy for metabolic dysfunction-associated steatohepatitis: November 2025 updates to AASLD Practice Guidance Introducing Saul J. Karpen, MD, Ph D, the 77th President of AASLDEpigenetic repression of hepatocyte Fox O1 disrupts local immune homeostasis and promotes liver inflammation Reply: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment Letter to the Editor: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment Hepatic ischemia reperfusion injury: Underlying mechanisms and concepts in liver surgery and liver transplantation Semaglutide therapy for metabolic dysfunction-associated steatohepatitis: November 2025 updates to AASLD Practice Guidance Introducing Saul J. Karpen, MD, Ph D, the 77th President of AASLDEpigenetic repression of hepatocyte Fox O1 disrupts local immune homeostasis and promotes liver inflammation Reply: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment Letter to the Editor: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment Hepatic ischemia reperfusion injury: Underlying mechanisms and concepts in liver surgery and liver transplantation Semaglutide therapy for metabolic dysfunction-associated steatohepatitis: November 2025 updates to AASLD Practice Guidance Introducing Saul J. Karpen, MD, Ph D, the 77th President of AASLDEpigenetic repression of hepatocyte Fox O1 disrupts local immune homeostasis and promotes liver inflammation Reply: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment Letter to the Editor: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment Hepatic ischemia reperfusion injury: Underlying mechanisms and concepts in liver surgery and liver transplantation Hepatic ischemia reperfusion injury: Underlying mechanisms and concepts in liver surgery and liver transplantation Semaglutide therapy for metabolic dysfunction-associated steatohepatitis: November 2025 updates to AASLD Practice Guidance Semaglutide therapy for metabolic dysfunction-associated steatohepatitis: November 2025 updates to AASLD Practice Guidance Introducing Saul J. Karpen, MD, Ph D, the 77th President of AASLD Introducing Saul J. Karpen, MD, Ph D, the 77th President of AASLD Epigenetic repression of hepatocyte Fox O1 disrupts local immune homeostasis and promotes liver inflammation Epigenetic repression of hepatocyte Fox O1 disrupts local immune homeostasis and promotes liver inflammation Reply: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment Reply: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment Letter to the Editor: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment Letter to the Editor: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment AASLD Practice Guidance on risk stratification and management of portal... Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial... AASLD Practice Guidance on the clinical assessment and management of... Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in... AASLD Practice Guidance on prevention, diagnosis, and treatment of... AASLD Practice Guidance on risk stratification and management of portal... Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial... AASLD Practice Guidance on the clinical assessment and management of... Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in... AASLD Practice Guidance on prevention, diagnosis, and treatment of... AASLD Practice Guidance on risk stratification and management of portal... Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial... AASLD Practice Guidance on the clinical assessment and management of... Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in... AASLD Practice Guidance on prevention, diagnosis, and treatment of... AASLD Practice Guidance on risk stratification and management of portal... Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial... AASLD Practice Guidance on the clinical assessment and management of... Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in... AASLD Practice Guidance on prevention, diagnosis, and treatment of... AASLD Practice Guidance on risk stratification and management of portal... Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial... AASLD Practice Guidance on the clinical assessment and management of... Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in... AASLD Practice Guidance on prevention, diagnosis, and treatment of... AASLD Practice Guidance on risk stratification and management of portal... Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial... AASLD Practice Guidance on the clinical assessment and management of... Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in... AASLD Practice Guidance on prevention, diagnosis, and treatment of... AASLD Practice Guidance on risk stratification and management of portal... Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial... AASLD Practice Guidance on the clinical assessment and management of... Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in... AASLD Practice Guidance on prevention, diagnosis, and treatment of... AASLD Practice Guidance on risk stratification and management of portal... Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial... AASLD Practice Guidance on the clinical assessment and management of... Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in... AASLD Practice Guidance on prevention, diagnosis, and treatment of... Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma AASLD guidelines for treatment of chronic hepatitis B Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma AASLD guidelines for treatment of chronic hepatitis B Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma AASLD guidelines for treatment of chronic hepatitis B Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma AASLD guidelines for treatment of chronic hepatitis B Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma AASLD guidelines for treatment of chronic hepatitis B Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma AASLD guidelines for treatment of chronic hepatitis B Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma AASLD guidelines for treatment of chronic hepatitis B AASLD guidelines for treatment of chronic hepatitis B sent right to your email inbox Browse Journal Content Register on the website Subscribe Get e TOC Alerts Support:Legal Disclaimer Terms of Use Open Access Policy Your California Privacy Choices -Wolters Kluwer Health, Inc. All rights reserved. | . sent right to your email inbox Browse Journal Content Register on the website Subscribe Get e TOC Alerts Support: sent right to your email inbox sent right to your email inbox sent right to your email inbox Browse Journal Content Register on the website Subscribe Get e TOC Alerts Support: Browse Journal Content Register on the website Subscribe Get e TOC Alerts Browse Journal Content Register on the website Subscribe Get e TOC Alerts Register on the website Get e TOC Alerts Support: Support: Support: Support: Legal Disclaimer Terms of Use Open Access Policy Your California Privacy Choices -Wolters Kluwer Health, Inc. All rights reserved. | . Legal Disclaimer Terms of Use Open Access Policy Your California Privacy Choices",
    "sections": [
      {
        "heading": "",
        "level": 3,
        "content": [
          "Articles Articles",
          "Advanced Search",
          "Subscribe Register Login Home Browse Articles in Press Current Issue All Issues Collections Video Gallery Review Articles Graphical Abstracts Top Cited Articles Top Altmetric Articles Multi-journal Article Collections The Future of Hepatology2024 Impact Factor: Top Cited Articles About About the Journal About AASLDEditorial Board Instructions for Authors Advertising Permissions Open Access Reprints For Authors Instructions for Authors Submit an Article Language Editing Services Graphical Abstract Guidelines Author Promotion Toolkit Resources Publish with Us AASLD Career Center Joint GI Society Statement on Racism What is Hepatology looking for 2.0? COVID-19 Resources Liver Learning Liver Connect Forums Become a Member AASLD Guidelines Submit an Article",
          "Subscribe Register Login",
          "Home Browse Articles in Press Current Issue All Issues Collections Video Gallery Review Articles Graphical Abstracts Top Cited Articles Top Altmetric Articles Multi-journal Article Collections The Future of Hepatology2024 Impact Factor: Top Cited Articles About About the Journal About AASLDEditorial Board Instructions for Authors Advertising Permissions Open Access Reprints For Authors Instructions for Authors Submit an Article Language Editing Services Graphical Abstract Guidelines Author Promotion Toolkit Resources Publish with Us AASLD Career Center Joint GI Society Statement on Racism What is Hepatology looking for 2.0? COVID-19 Resources Liver Learning Liver Connect Forums Become a Member AASLD Guidelines Submit an Article",
          "Articles Articles",
          "Advanced Search",
          "September 2022 - Volume 76 - Issue 3Previous Article Next Article for this Video.. Hepatic ischemia reperfusion injury: Underlying mechanisms and concepts in liver surgery and liver transplantation Semaglutide therapy for metabolic dysfunction-associated steatohepatitis: November 2025 updates to AASLD Practice Guidance Introducing Saul J. Karpen, MD, Ph D, the 77th President of AASLDEpigenetic repression of hepatocyte Fox O1 disrupts local immune homeostasis and promotes liver inflammation Reply: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment Letter to the Editor: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment AASLD Practice Guidance on risk stratification and management of portal... Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial... AASLD Practice Guidance on the clinical assessment and management of... Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in... AASLD Practice Guidance on prevention, diagnosis, and treatment of... Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma AASLD guidelines for treatment of chronic hepatitis B",
          "September 2022 - Volume 76 - Issue 3Previous Article Next Article for this Video.. Hepatic ischemia reperfusion injury: Underlying mechanisms and concepts in liver surgery and liver transplantation Semaglutide therapy for metabolic dysfunction-associated steatohepatitis: November 2025 updates to AASLD Practice Guidance Introducing Saul J. Karpen, MD, Ph D, the 77th President of AASLDEpigenetic repression of hepatocyte Fox O1 disrupts local immune homeostasis and promotes liver inflammation Reply: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment Letter to the Editor: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment AASLD Practice Guidance on risk stratification and management of portal... Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial... AASLD Practice Guidance on the clinical assessment and management of... Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in... AASLD Practice Guidance on prevention, diagnosis, and treatment of... Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma AASLD guidelines for treatment of chronic hepatitis B",
          "September 2022 - Volume 76 - Issue 3Previous Article Next Article for this Video.. Hepatic ischemia reperfusion injury: Underlying mechanisms and concepts in liver surgery and liver transplantation Semaglutide therapy for metabolic dysfunction-associated steatohepatitis: November 2025 updates to AASLD Practice Guidance Introducing Saul J. Karpen, MD, Ph D, the 77th President of AASLDEpigenetic repression of hepatocyte Fox O1 disrupts local immune homeostasis and promotes liver inflammation Reply: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment Letter to the Editor: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment AASLD Practice Guidance on risk stratification and management of portal... Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial... AASLD Practice Guidance on the clinical assessment and management of... Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in... AASLD Practice Guidance on prevention, diagnosis, and treatment of... Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma AASLD guidelines for treatment of chronic hepatitis B",
          "September 2022 - Volume 76 - Issue 3Previous Article Next Article",
          "September 2022 - Volume 76 - Issue 3Previous Article Next Article",
          "September 2022 - Volume 76 - Issue 3Previous Article Next Article",
          "September 2022 - Volume 76 - Issue 3Previous Article Next Article",
          "September 2022 - Volume 76 - Issue 3Previous Article Next Article",
          "September 2022 - Volume 76 - Issue 3Previous Article Next Article",
          "September 2022 - Volume 76 - Issue 3Previous Article Next Article",
          "September 2022 - Volume 76 - Issue 3Previous Article Next Article",
          "September 2022 - Volume 76 - Issue 3Previous Article Next Article",
          "September 2022 - Volume 76 - Issue 3",
          "Previous Article Next Article",
          "for this Video.. Hepatic ischemia reperfusion injury: Underlying mechanisms and concepts in liver surgery and liver transplantation Semaglutide therapy for metabolic dysfunction-associated steatohepatitis: November 2025 updates to AASLD Practice Guidance Introducing Saul J. Karpen, MD, Ph D, the 77th President of AASLDEpigenetic repression of hepatocyte Fox O1 disrupts local immune homeostasis and promotes liver inflammation Reply: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment Letter to the Editor: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment AASLD Practice Guidance on risk stratification and management of portal... Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial... AASLD Practice Guidance on the clinical assessment and management of... Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in... AASLD Practice Guidance on prevention, diagnosis, and treatment of... Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma AASLD guidelines for treatment of chronic hepatitis B",
          "for this Video.. Hepatic ischemia reperfusion injury: Underlying mechanisms and concepts in liver surgery and liver transplantation Semaglutide therapy for metabolic dysfunction-associated steatohepatitis: November 2025 updates to AASLD Practice Guidance Introducing Saul J. Karpen, MD, Ph D, the 77th President of AASLDEpigenetic repression of hepatocyte Fox O1 disrupts local immune homeostasis and promotes liver inflammation Reply: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment Letter to the Editor: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment AASLD Practice Guidance on risk stratification and management of portal... Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial... AASLD Practice Guidance on the clinical assessment and management of... Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in... AASLD Practice Guidance on prevention, diagnosis, and treatment of... Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma AASLD guidelines for treatment of chronic hepatitis B",
          "for this Video.. Hepatic ischemia reperfusion injury: Underlying mechanisms and concepts in liver surgery and liver transplantation Semaglutide therapy for metabolic dysfunction-associated steatohepatitis: November 2025 updates to AASLD Practice Guidance Introducing Saul J. Karpen, MD, Ph D, the 77th President of AASLDEpigenetic repression of hepatocyte Fox O1 disrupts local immune homeostasis and promotes liver inflammation Reply: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment Letter to the Editor: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment AASLD Practice Guidance on risk stratification and management of portal... Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial... AASLD Practice Guidance on the clinical assessment and management of... Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in... AASLD Practice Guidance on prevention, diagnosis, and treatment of... Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma AASLD guidelines for treatment of chronic hepatitis B",
          "for this Video.. Hepatic ischemia reperfusion injury: Underlying mechanisms and concepts in liver surgery and liver transplantation Semaglutide therapy for metabolic dysfunction-associated steatohepatitis: November 2025 updates to AASLD Practice Guidance Introducing Saul J. Karpen, MD, Ph D, the 77th President of AASLDEpigenetic repression of hepatocyte Fox O1 disrupts local immune homeostasis and promotes liver inflammation Reply: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment Letter to the Editor: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment AASLD Practice Guidance on risk stratification and management of portal... Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial... AASLD Practice Guidance on the clinical assessment and management of... Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in... AASLD Practice Guidance on prevention, diagnosis, and treatment of... Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma AASLD guidelines for treatment of chronic hepatitis B",
          "for this Video..",
          "for this Video..",
          "for this Video..",
          "for this Video..",
          "for this Video..",
          "for this Video..",
          "for this Video..",
          "for this Video..",
          "Hepatic ischemia reperfusion injury: Underlying mechanisms and concepts in liver surgery and liver transplantation Semaglutide therapy for metabolic dysfunction-associated steatohepatitis: November 2025 updates to AASLD Practice Guidance Introducing Saul J. Karpen, MD, Ph D, the 77th President of AASLDEpigenetic repression of hepatocyte Fox O1 disrupts local immune homeostasis and promotes liver inflammation Reply: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment Letter to the Editor: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment",
          "Hepatic ischemia reperfusion injury: Underlying mechanisms and concepts in liver surgery and liver transplantation Semaglutide therapy for metabolic dysfunction-associated steatohepatitis: November 2025 updates to AASLD Practice Guidance Introducing Saul J. Karpen, MD, Ph D, the 77th President of AASLDEpigenetic repression of hepatocyte Fox O1 disrupts local immune homeostasis and promotes liver inflammation Reply: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment Letter to the Editor: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment",
          "Hepatic ischemia reperfusion injury: Underlying mechanisms and concepts in liver surgery and liver transplantation Semaglutide therapy for metabolic dysfunction-associated steatohepatitis: November 2025 updates to AASLD Practice Guidance Introducing Saul J. Karpen, MD, Ph D, the 77th President of AASLDEpigenetic repression of hepatocyte Fox O1 disrupts local immune homeostasis and promotes liver inflammation Reply: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment Letter to the Editor: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment",
          "Hepatic ischemia reperfusion injury: Underlying mechanisms and concepts in liver surgery and liver transplantation Semaglutide therapy for metabolic dysfunction-associated steatohepatitis: November 2025 updates to AASLD Practice Guidance Introducing Saul J. Karpen, MD, Ph D, the 77th President of AASLDEpigenetic repression of hepatocyte Fox O1 disrupts local immune homeostasis and promotes liver inflammation Reply: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment Letter to the Editor: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment",
          "Hepatic ischemia reperfusion injury: Underlying mechanisms and concepts in liver surgery and liver transplantation Semaglutide therapy for metabolic dysfunction-associated steatohepatitis: November 2025 updates to AASLD Practice Guidance Introducing Saul J. Karpen, MD, Ph D, the 77th President of AASLDEpigenetic repression of hepatocyte Fox O1 disrupts local immune homeostasis and promotes liver inflammation Reply: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment Letter to the Editor: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment",
          "Hepatic ischemia reperfusion injury: Underlying mechanisms and concepts in liver surgery and liver transplantation Semaglutide therapy for metabolic dysfunction-associated steatohepatitis: November 2025 updates to AASLD Practice Guidance Introducing Saul J. Karpen, MD, Ph D, the 77th President of AASLDEpigenetic repression of hepatocyte Fox O1 disrupts local immune homeostasis and promotes liver inflammation Reply: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment Letter to the Editor: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment",
          "Hepatic ischemia reperfusion injury: Underlying mechanisms and concepts in liver surgery and liver transplantation Semaglutide therapy for metabolic dysfunction-associated steatohepatitis: November 2025 updates to AASLD Practice Guidance Introducing Saul J. Karpen, MD, Ph D, the 77th President of AASLDEpigenetic repression of hepatocyte Fox O1 disrupts local immune homeostasis and promotes liver inflammation Reply: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment Letter to the Editor: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment"
        ]
      },
      {
        "heading": "",
        "level": 2,
        "content": [
          "Hepatic ischemia reperfusion injury: Underlying mechanisms and concepts in liver surgery and liver transplantation Semaglutide therapy for metabolic dysfunction-associated steatohepatitis: November 2025 updates to AASLD Practice Guidance Introducing Saul J. Karpen, MD, Ph D, the 77th President of AASLDEpigenetic repression of hepatocyte Fox O1 disrupts local immune homeostasis and promotes liver inflammation Reply: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment Letter to the Editor: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment",
          "Hepatic ischemia reperfusion injury: Underlying mechanisms and concepts in liver surgery and liver transplantation"
        ]
      },
      {
        "heading": "Hepatic ischemia reperfusion injury: Underlying mechanisms and concepts in liver surgery and liver transplantation",
        "level": 3,
        "content": [
          "Semaglutide therapy for metabolic dysfunction-associated steatohepatitis: November 2025 updates to AASLD Practice Guidance"
        ]
      },
      {
        "heading": "Semaglutide therapy for metabolic dysfunction-associated steatohepatitis: November 2025 updates to AASLD Practice Guidance",
        "level": 3,
        "content": [
          "Introducing Saul J. Karpen, MD, Ph D, the 77th President of AASLD"
        ]
      },
      {
        "heading": "Introducing Saul J. Karpen, MD, Ph D, the 77th President of AASLD",
        "level": 3,
        "content": [
          "Epigenetic repression of hepatocyte Fox O1 disrupts local immune homeostasis and promotes liver inflammation"
        ]
      },
      {
        "heading": "Epigenetic repression of hepatocyte Fox O1 disrupts local immune homeostasis and promotes liver inflammation",
        "level": 3,
        "content": [
          "Reply: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment"
        ]
      },
      {
        "heading": "Reply: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment",
        "level": 3,
        "content": [
          "Letter to the Editor: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment"
        ]
      },
      {
        "heading": "Letter to the Editor: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment",
        "level": 3,
        "content": [
          "AASLD Practice Guidance on risk stratification and management of portal... Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial... AASLD Practice Guidance on the clinical assessment and management of... Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in... AASLD Practice Guidance on prevention, diagnosis, and treatment of...",
          "AASLD Practice Guidance on risk stratification and management of portal... Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial... AASLD Practice Guidance on the clinical assessment and management of... Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in... AASLD Practice Guidance on prevention, diagnosis, and treatment of...",
          "AASLD Practice Guidance on risk stratification and management of portal... Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial... AASLD Practice Guidance on the clinical assessment and management of... Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in... AASLD Practice Guidance on prevention, diagnosis, and treatment of...",
          "AASLD Practice Guidance on risk stratification and management of portal... Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial... AASLD Practice Guidance on the clinical assessment and management of... Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in... AASLD Practice Guidance on prevention, diagnosis, and treatment of...",
          "AASLD Practice Guidance on risk stratification and management of portal... Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial... AASLD Practice Guidance on the clinical assessment and management of... Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in... AASLD Practice Guidance on prevention, diagnosis, and treatment of...",
          "AASLD Practice Guidance on risk stratification and management of portal... Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial... AASLD Practice Guidance on the clinical assessment and management of... Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in... AASLD Practice Guidance on prevention, diagnosis, and treatment of..."
        ]
      },
      {
        "heading": "",
        "level": 2,
        "content": [
          "AASLD Practice Guidance on risk stratification and management of portal... Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial... AASLD Practice Guidance on the clinical assessment and management of... Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in... AASLD Practice Guidance on prevention, diagnosis, and treatment of...",
          "AASLD Practice Guidance on risk stratification and management of portal... Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial... AASLD Practice Guidance on the clinical assessment and management of... Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in... AASLD Practice Guidance on prevention, diagnosis, and treatment of..."
        ]
      },
      {
        "heading": "AASLD Practice Guidance on risk stratification and management of portal...",
        "level": 3,
        "content": []
      },
      {
        "heading": "Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial...",
        "level": 3,
        "content": []
      },
      {
        "heading": "AASLD Practice Guidance on the clinical assessment and management of...",
        "level": 3,
        "content": []
      },
      {
        "heading": "Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in...",
        "level": 3,
        "content": []
      },
      {
        "heading": "AASLD Practice Guidance on prevention, diagnosis, and treatment of...",
        "level": 3,
        "content": [
          "Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma AASLD guidelines for treatment of chronic hepatitis B",
          "Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma AASLD guidelines for treatment of chronic hepatitis B",
          "Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma AASLD guidelines for treatment of chronic hepatitis B",
          "Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma AASLD guidelines for treatment of chronic hepatitis B",
          "Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma AASLD guidelines for treatment of chronic hepatitis B",
          "Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma AASLD guidelines for treatment of chronic hepatitis B"
        ]
      },
      {
        "heading": "",
        "level": 2,
        "content": [
          "Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma AASLD guidelines for treatment of chronic hepatitis B",
          "Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases"
        ]
      },
      {
        "heading": "Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases",
        "level": 2,
        "content": [
          "AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis"
        ]
      },
      {
        "heading": "AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis",
        "level": 2,
        "content": [
          "AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease"
        ]
      },
      {
        "heading": "AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease",
        "level": 2,
        "content": [
          "AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma"
        ]
      },
      {
        "heading": "AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma",
        "level": 2,
        "content": [
          "AASLD guidelines for treatment of chronic hepatitis B"
        ]
      },
      {
        "heading": "AASLD guidelines for treatment of chronic hepatitis B",
        "level": 2,
        "content": [
          "sent right to your email inbox Browse Journal Content Register on the website Subscribe Get e TOC Alerts Support:Legal Disclaimer Terms of Use Open Access Policy Your California Privacy Choices -Wolters Kluwer Health, Inc. All rights reserved. | .",
          "sent right to your email inbox Browse Journal Content Register on the website Subscribe Get e TOC Alerts Support:",
          "sent right to your email inbox",
          "sent right to your email inbox",
          "sent right to your email inbox",
          "sent right to your email inbox",
          "Browse Journal Content Register on the website Subscribe Get e TOC Alerts Support:",
          "Browse Journal Content Register on the website Subscribe Get e TOC Alerts",
          "Browse Journal Content Register on the website Subscribe Get e TOC Alerts",
          "Browse Journal Content",
          "Legal Disclaimer Terms of Use Open Access Policy Your California Privacy Choices -Wolters Kluwer Health, Inc. All rights reserved. | .",
          "we use cookies and similar technologies. We use data collected through these technologies for various purposes, including to enhance website functionality, remember your preferences, show the most relevant content, and show the most useful ads. You can select your preferences by clicking the link. For more information, please review our Privacy & Cookie Notice When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device. Because we respect your right to privacy, you can choose not to allow certain types of cookies on our website. Click on the different category headings to find out more and manage your cookie preferences. However, blocking some types of cookies may impact your experience on the site and the services we are able to offer. Privacy & Cookie Notice Allow All Manage Consent Preferences Always Active These cookies are necessary for the website to function. They are usually set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, this may have an effect on the proper functioning of (parts of) the site. View Vendor DetailsThese cookies enable the website to provide enhanced functionality, user experience and personalization, and may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies, then some or all of these services may not function properly. View Vendor DetailsThese cookies support analytic services that measure and improve the performance of our site. They help us know which pages are the most and least popular and see how visitors move around the site. View Vendor DetailsThese cookies may collect insights to issue personalized content and advertising on our own and other websites, and may be set through our site by third party providers. If you do not allow these cookies, you may still see basic advertising on your browser that is generic and not based on your interests. View Vendor DetailsBack Button Vendors List Search Icon Filter Icon Clearcheckbox labellabel Apply Cancel Consent Leg. Interestcheckbox labellabelcheckbox labellabelcheckbox labellabel Reject All Confirm My Choices",
          "we use cookies and similar technologies. We use data collected through these technologies for various purposes, including to enhance website functionality, remember your preferences, show the most relevant content, and show the most useful ads. You can select your preferences by clicking the link. For more information, please review our Privacy & Cookie Notice",
          "we use cookies and similar technologies. We use data collected through these technologies for various purposes, including to enhance website functionality, remember your preferences, show the most relevant content, and show the most useful ads. You can select your preferences by clicking the link. For more information, please review our Privacy & Cookie Notice",
          "we use cookies and similar technologies. We use data collected through these technologies for various purposes, including to enhance website functionality, remember your preferences, show the most relevant content, and show the most useful ads. You can select your preferences by clicking the link. For more information, please review our Privacy & Cookie Notice",
          "we use cookies and similar technologies. We use data collected through these technologies for various purposes, including to enhance website functionality, remember your preferences, show the most relevant content, and show the most useful ads. You can select your preferences by clicking the link. For more information, please review our Privacy & Cookie Notice",
          "we use cookies and similar technologies. We use data collected through these technologies for various purposes, including to enhance website functionality, remember your preferences, show the most relevant content, and show the most useful ads. You can select your preferences by clicking the link. For more information, please review our Privacy & Cookie Notice"
        ]
      },
      {
        "heading": "",
        "level": 2,
        "content": [
          "When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device. Because we respect your right to privacy, you can choose not to allow certain types of cookies on our website. Click on the different category headings to find out more and manage your cookie preferences. However, blocking some types of cookies may impact your experience on the site and the services we are able to offer. Privacy & Cookie Notice",
          "Manage Consent Preferences Always Active These cookies are necessary for the website to function. They are usually set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, this may have an effect on the proper functioning of (parts of) the site. View Vendor DetailsThese cookies enable the website to provide enhanced functionality, user experience and personalization, and may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies, then some or all of these services may not function properly. View Vendor DetailsThese cookies support analytic services that measure and improve the performance of our site. They help us know which pages are the most and least popular and see how visitors move around the site. View Vendor DetailsThese cookies may collect insights to issue personalized content and advertising on our own and other websites, and may be set through our site by third party providers. If you do not allow these cookies, you may still see basic advertising on your browser that is generic and not based on your interests. View Vendor Details"
        ]
      },
      {
        "heading": "Manage Consent Preferences",
        "level": 3,
        "content": [
          "Always Active These cookies are necessary for the website to function. They are usually set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, this may have an effect on the proper functioning of (parts of) the site. View Vendor Details",
          "Always Active",
          "Always Active",
          "These cookies are necessary for the website to function. They are usually set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, this may have an effect on the proper functioning of (parts of) the site. View Vendor Details",
          "These cookies are necessary for the website to function. They are usually set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, this may have an effect on the proper functioning of (parts of) the site.",
          "View Vendor Details",
          "These cookies enable the website to provide enhanced functionality, user experience and personalization, and may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies, then some or all of these services may not function properly. View Vendor Details",
          "These cookies enable the website to provide enhanced functionality, user experience and personalization, and may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies, then some or all of these services may not function properly. View Vendor Details",
          "These cookies enable the website to provide enhanced functionality, user experience and personalization, and may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies, then some or all of these services may not function properly.",
          "View Vendor Details",
          "These cookies support analytic services that measure and improve the performance of our site. They help us know which pages are the most and least popular and see how visitors move around the site. View Vendor Details",
          "These cookies support analytic services that measure and improve the performance of our site. They help us know which pages are the most and least popular and see how visitors move around the site. View Vendor Details",
          "These cookies support analytic services that measure and improve the performance of our site. They help us know which pages are the most and least popular and see how visitors move around the site.",
          "View Vendor Details",
          "These cookies may collect insights to issue personalized content and advertising on our own and other websites, and may be set through our site by third party providers. If you do not allow these cookies, you may still see basic advertising on your browser that is generic and not based on your interests. View Vendor Details",
          "These cookies may collect insights to issue personalized content and advertising on our own and other websites, and may be set through our site by third party providers. If you do not allow these cookies, you may still see basic advertising on your browser that is generic and not based on your interests. View Vendor Details",
          "These cookies may collect insights to issue personalized content and advertising on our own and other websites, and may be set through our site by third party providers. If you do not allow these cookies, you may still see basic advertising on your browser that is generic and not based on your interests.",
          "View Vendor Details",
          "Back Button Vendors List Search Icon Filter Icon Clearcheckbox labellabel Apply Cancel Consent Leg. Interestcheckbox labellabelcheckbox labellabelcheckbox labellabel",
          "Back Button Vendors List Search Icon Filter Icon Clearcheckbox labellabel Apply Cancel",
          "Back Button Vendors List"
        ]
      },
      {
        "heading": "Vendors List",
        "level": 3,
        "content": [
          "Search Icon Filter Icon Clearcheckbox labellabel Apply Cancel",
          "Search Icon",
          "Filter Icon",
          "Clearcheckbox labellabel Apply Cancel",
          "Clearcheckbox labellabel Apply Cancel",
          "checkbox labellabel Apply Cancel",
          "checkbox labellabel",
          "checkbox labellabel",
          "checkbox labellabel",
          "Apply Cancel",
          "Consent Leg. Interestcheckbox labellabelcheckbox labellabelcheckbox labellabel",
          "Consent Leg. Interestcheckbox labellabelcheckbox labellabelcheckbox labellabel",
          "Consent Leg. Interestcheckbox labellabelcheckbox labellabelcheckbox labellabel",
          "Consent Leg. Interest",
          "checkbox labellabelcheckbox labellabelcheckbox labellabel",
          "checkbox labellabel",
          "checkbox labellabel",
          "checkbox labellabel",
          "Reject All Confirm My Choices",
          "Reject All Confirm My Choices"
        ]
      }
    ],
    "tables": [],
    "links": [
      {
        "text": "AASLD Publications",
        "url": "/aasldpubs/Pages/default.aspx"
      },
      {
        "text": "Hepatology",
        "url": "/hep/Pages/default.aspx"
      },
      {
        "text": "Liver Transplantation",
        "url": "/lt/Pages/default.aspx"
      },
      {
        "text": "Hepatology Communications",
        "url": "/hepcomm/Pages/default.aspx"
      },
      {
        "text": "Clinical Liver Disease",
        "url": "/cld/Pages/default.aspx"
      },
      {
        "text": "AASLD Publications",
        "url": "/aasldpubs/Pages/default.aspx"
      },
      {
        "text": "Hepatology",
        "url": "/hep/Pages/default.aspx"
      },
      {
        "text": "Liver Transplantation",
        "url": "/lt/Pages/default.aspx"
      },
      {
        "text": "Hepatology Communications",
        "url": "/hepcomm/Pages/default.aspx"
      },
      {
        "text": "Clinical Liver Disease",
        "url": "/cld/Pages/default.aspx"
      },
      {
        "text": "AASLD Publications",
        "url": "/aasldpubs/Pages/default.aspx"
      },
      {
        "text": "Hepatology",
        "url": "/hep/Pages/default.aspx"
      },
      {
        "text": "Liver Transplantation",
        "url": "/lt/Pages/default.aspx"
      },
      {
        "text": "Hepatology Communications",
        "url": "/hepcomm/Pages/default.aspx"
      },
      {
        "text": "Clinical Liver Disease",
        "url": "/cld/Pages/default.aspx"
      },
      {
        "text": "Register",
        "url": "https://journals.lww.com/hep/pages/register.aspx?ContextUrl=%2fhep%2ffulltext%2f2022%2f09000%2faasld_practice_guidance__palliative_care_and.28.aspx"
      },
      {
        "text": "Subscribe to journalSubscribe",
        "url": "https://shop.lww.com/p/0270-9139"
      },
      {
        "text": "Get new issue alertsGet alerts",
        "url": "javascript:javascript: alerts_ShowSubscribeeTOCPopup('Hepatology','hep','eTOC', 'eTOC');;"
      },
      {
        "text": "AASLD Member? Login here",
        "url": "https://login.journals.lww.com/OneID/Login.aspx?PartnerIdpId=https://my.aasld.org&Login_type=SocietySso&returnUrl=https%3a%2f%2fjournals.lww.com%2flt%2fpages%2fdefault.aspx"
      },
      {
        "text": "Subscribe to eTOC",
        "url": "javascript:javascript: alerts_ShowSubscribeeTOCPopup('Hepatology','hep','eTOC', 'eTOC');;"
      }
    ],
    "recommendations": [],
    "clinical_values": [],
    "word_count": 7282,
    "paragraph_count": 239,
    "section_count": 23,
    "table_count": 0
  },
  "cleaned_at": "2025-11-11T17:30:34.293890"
}